JM
Publicaties op Oncologisch.com
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition wi...
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Behandeling Response ...
Tadalafil plus neoadjuvant nivolumab bij resectabel hoofd-halscarcinoom: immuunsignaturen
Durvalumab plus tremelimumab met of zonder RT bij NSCLC: COAST fase II